Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:45 PM
Ignite Modification Date:
2025-12-24 @ 2:45 PM
NCT ID:
NCT00185159
Eligibility Criteria:
Inclusion Criteria:
* Diabetes mellitus type 2, defined as fasting blood glucose of greater than or equal to 126 mg/dL;
* Presence of at least one of the following cardiovascular risk factors:
1. total cholesterol greater than 200 mg/dL or statin treatment,
2. High density lipoprotein (HDL) less than 40 mg/dL,
3. triglycerides greater than 150 mg/dL and less than 400 mg/dL,
4. blood pressure greater than or equal to 130/80 mmHg,
5. Body mass index (BMI) greater than 28 kg/m2,
6. waist circumference greater than 102 cm for men and greater than 88 cm for women,
7. smoking of more than 5 cigarettes a day;
* Normoalbuminuria at screening
Exclusion Criteria:
* Severe uncontrolled hyperlipidemia;
* Documented renal and/or renal-vascular disease;
* Myocardial infarction, stroke or myocardial revascularization within the last 6 months;
* History of alcohol and/or drug abuse;
* Allergic reaction, lack of response or contraindication to angiotensin receptor blockers (ARBs);
* Current treatment with an ARB or angiotensin converting enzyme (ACE) inhibitor
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00185159
Study Brief:
Protocol Section:
NCT00185159